{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:19:31Z","timestamp":1788315571748,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015077","name":"Wydzia\u0142 Lekarski, Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.cjca.2019.08.001","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T02:00:20Z","timestamp":1565229620000},"page":"119-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clot Lysis Time Predicts Stroke During Anticoagulant Therapy in Patients with Atrial Fibrillation"],"prefix":"10.1016","volume":"36","author":[{"given":"Leszek","family":"Drabik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Konieczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.08.001_bib1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"7","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.08.001_bib2","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1378\/chest.126.6.1938","article-title":"Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis","volume":"126","author":"Reynolds","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2019.08.001_bib3","first-page":"1371","article-title":"2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.08.001_bib4","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/eurheartj\/eht024","article-title":"Biomarkers in atrial fibrillation: a clinical review","volume":"34","author":"Hijazi","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.08.001_bib5","first-page":"634","article-title":"Prothrombotic state in atrial fibrillation patients with one additional risk factor of the CHA2DS2-VASc score (beyond sex)","volume":"35","author":"G\u0142owicki","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.08.001_bib6","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2017.01.057","article-title":"Prethrombotic state in young very low-risk patients with atrial fibrillation","volume":"69","author":"Hobbelt","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.08.001_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow\u2019s triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2019.08.001_bib8","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.08.001_bib9","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.5603\/KP.2018.0134","article-title":"Association of cardiac troponin I with prothrombotic alterations in atrial fibrillation","volume":"76","author":"Matusik","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2019.08.001_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2015.05.028","article-title":"Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation","volume":"136","author":"Drabik","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2019.08.001_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/01.mbc.0000114440.81125.bd","article-title":"d-Dimer can predict survival in patients with chronic atrial fibrillation","volume":"15","author":"Mah\u00e9","year":"2004","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 1","key":"10.1016\/j.cjca.2019.08.001_bib12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jth.12229","article-title":"Fibrin(ogen) and thrombotic disease","volume":"11","author":"Ari\u00ebns","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.08.001_bib13","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: A role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2019.08.001_bib14","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/STROKEAHA.117.018143","article-title":"Fibrin clot permeability as a predictor of stroke and bleeding in anticoagulated patients with atrial fibrillation","volume":"48","author":"Drabik","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2019.08.001_bib15","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1538-7836.2012.04883.x","article-title":"An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values","volume":"10","author":"Pieters","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.08.001_bib16","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.thromres.2015.08.007","article-title":"Vitamin K antagonists favourably modulate fibrin clot properties in patients with atrial fibrillation as early as after 3 days of treatment: Relation to coagulation factors and thrombin generation","volume":"136","author":"Z\u0105bczyk","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2019.08.001_bib17","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurheartj\/ehy013","article-title":"Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy","volume":"39","author":"Sumaya","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.08.001_bib18","doi-asserted-by":"crossref","first-page":"d124","DOI":"10.1136\/bmj.d124","article-title":"Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study","volume":"342","author":"Olesen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2019.08.001_bib19","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A\u00a0novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2019.08.001_bib20","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2019.08.001_bib21","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1160\/TH11-09-0662","article-title":"A\u00a0history of early stent thrombosis is associated with prolonged clot lysis time","volume":"107","author":"Pankiw-Bembenek","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.08.001_bib22","first-page":"541","article-title":"Experience from a multicentre stroke register: a preliminary report","volume":"54","author":"Hatano","year":"1976","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.cjca.2019.08.001_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"issue":"212","key":"10.1016\/j.cjca.2019.08.001_bib24","first-page":"381","article-title":"How to assess fibrinogen levels and fibrin clot properties in clinical practice?","volume":"1","author":"Undas","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.cjca.2019.08.001_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2017.05.060","article-title":"Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation","volume":"243","author":"Matusik","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2019.08.001_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.20452\/pamw.1101","article-title":"Thromboembolic events are associated with prolonged clot lysis time in patients with permanent atrial fibrillation","volume":"121","author":"Z\u0105bczyk","year":"2011","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.cjca.2019.08.001_bib27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0037-1616936","article-title":"Role of von Willebrand factor in vascular disease","volume":"29","author":"Paulinska","year":"2009","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.cjca.2019.08.001_bib28","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.STR.0000236840.00467.84","article-title":"Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation","volume":"37","author":"Lip","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2019.08.001_bib29","first-page":"278","article-title":"Association of inflammatory and hemostatic markers with stroke and thromboembolic events in atrial fibrillation: a systematic review and meta-analysis","volume":"31","author":"Wu","year":"2015","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.08.001_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.thromres.2014.06.031","article-title":"Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation","volume":"134","author":"Skov","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2019.08.001_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1160\/TH14-01-0032","article-title":"Fibrin clot properties and their modulation in thrombotic disorders","volume":"112","author":"Undas","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.08.001_bib32","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1160\/TH14-10-0859","article-title":"Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula","volume":"113","author":"Sj\u00f6gren","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.08.001_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5603\/KP.a2017.0241","article-title":"Evaluation of the recommended prevention of thrombosis in hospitalised patients with atrial fibrillation and high thromboembolism risk","volume":"76","author":"Gorczyca-Michta","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2019.08.001_bib34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.5603\/KP.a2018.0027","article-title":"Comparison of clinical characteristics of real-life atrial fibrillation patients treated with vitamin K antagonists, dabigatran, and rivaroxaban: results from the CRAFT study","volume":"76","author":"Balsam","year":"2018","journal-title":"Kardiol Pol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19311432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19311432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:19Z","timestamp":1760107279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19311432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0828282X19311432"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.08.001","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clot Lysis Time Predicts Stroke During Anticoagulant Therapy in Patients with Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}